| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | AZ-3146 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.01 |
| mRNA | semagacestat | CTRPv2 | pan-cancer | AAC | -0.096 | 0.01 |
| mRNA | procarbazine | CTRPv2 | pan-cancer | AAC | -0.1 | 0.01 |
| mRNA | Bosutinib | CTRPv2 | pan-cancer | AAC | -0.088 | 0.02 |
| mRNA | BIBW2992 | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |
| mRNA | apicidin | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | I-BET151 | CTRPv2 | pan-cancer | AAC | -0.077 | 0.02 |
| mRNA | BRD9647 | CTRPv2 | pan-cancer | AAC | 0.093 | 0.02 |
| mRNA | JQ-1:vorinostat (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.082 | 0.02 |
| mRNA | Vandetanib | CTRPv2 | pan-cancer | AAC | -0.091 | 0.02 |